KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 127 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $292,000 | -15.4% | 85,756 | -6.6% | 0.00% | 0.0% |
| Q2 2018 | $345,000 | +1.2% | 91,831 | +10.3% | 0.00% | 0.0% |
| Q1 2018 | $341,000 | -13.0% | 83,286 | -1.2% | 0.00% | 0.0% |
| Q4 2017 | $392,000 | -45.3% | 84,306 | -16.6% | 0.00% | -50.0% |
| Q3 2017 | $717,000 | -0.6% | 101,041 | +1.3% | 0.00% | 0.0% |
| Q2 2017 | $721,000 | +17.8% | 99,711 | +0.3% | 0.00% | +100.0% |
| Q1 2017 | $612,000 | +12.7% | 99,376 | +7.3% | 0.00% | 0.0% |
| Q4 2016 | $543,000 | +8.6% | 92,626 | -1.5% | 0.00% | 0.0% |
| Q3 2016 | $500,000 | -22.1% | 94,074 | -3.0% | 0.00% | -50.0% |
| Q2 2016 | $642,000 | +28.1% | 97,024 | -9.6% | 0.00% | 0.0% |
| Q1 2016 | $501,000 | -7.6% | 107,311 | -0.1% | 0.00% | 0.0% |
| Q4 2015 | $542,000 | +54.4% | 107,401 | +7.8% | 0.00% | +100.0% |
| Q3 2015 | $351,000 | -64.7% | 99,631 | -0.1% | 0.00% | -66.7% |
| Q2 2015 | $995,000 | -24.0% | 99,696 | -3.0% | 0.00% | -25.0% |
| Q1 2015 | $1,309,000 | +13.9% | 102,821 | +26.6% | 0.00% | +33.3% |
| Q4 2014 | $1,149,000 | +1.3% | 81,211 | -1.5% | 0.00% | 0.0% |
| Q3 2014 | $1,134,000 | -14.4% | 82,456 | -4.3% | 0.00% | -25.0% |
| Q2 2014 | $1,325,000 | -8.7% | 86,121 | +1.1% | 0.00% | 0.0% |
| Q1 2014 | $1,451,000 | +40.2% | 85,176 | +6.5% | 0.00% | +33.3% |
| Q4 2013 | $1,035,000 | +35.6% | 79,946 | +5.8% | 0.00% | +50.0% |
| Q3 2013 | $763,000 | +34.3% | 75,566 | -0.6% | 0.00% | 0.0% |
| Q2 2013 | $568,000 | – | 75,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |